Akbar Shakoor is an Ophthalmology physician affiliated with University of Utah. OpenAlex indexes 80 publications with 1,260 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
65 S Mario Capecchi Dr
Salt Lake City, UT 841320005
Telephone
801-581-2352Provider last certified this registry record 19 Oct 2021.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year20253 payments
- Carl Zeiss Meditec USA, Inc.Program year20251 payment
- Dutch Ophthalmic, USAProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
95.6%Antineovascularisation agents93.6%Faricimab-svoa100%Part B, office-administered≥41 patientsCorticosteroid0.7%Prednisolone Acetate100%Part D≥44 patients+ 5 more classes in this area
Cancer & immunology
3.7%Vascular Endothelial Growth Factor Inhibitor3.4%Aflibercept100%Part B, office-administered≥43 patientsTNF inhibitor0.1%Humira(Cf) Pen100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
0.4%Cyclooxygenase Inhibitor0.4%Ketorolac Tromethamine100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Effect of Metagenomic Sequencing on Patient Clinical Outcomes for Intraocular Infections: A Multicenter Randomized Controlled Trial
American Journal of Ophthalmology
2025 - Pathogen-Associated Visual Outcomes Following Postprocedure Endophthalmitis
American Journal of Ophthalmology
2025 - Optic Disc Edema Is an Under-Recognized Feature of Birdshot Chorioretinitis
Journal of Neuro-Ophthalmology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Frederick Welt, MD
University of Utah
Jennifer Majersik, MD
University of Utah
Richard Gurgel, MD
University of Utah
Fuad Shihab, MD
University of Utah
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”